Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses effectively suppress growth of malignant pleural mesothelioma-Reference-Cited by-同舟云学术

Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses effectively suppress growth of malignant pleural mesothelioma

Published:2016-12-01 Issue:1 Volume:108 Page:116-123
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Harada Akiko¹,Uchino Junji²³,Harada Taishi¹,Nakagaki Noriaki¹,Hisasue Junko¹,Fujita Masaki²,Takayama Koichi³

Affiliation:

1. Research Institute for Diseases of the Chest; Graduate School of Medical Sciences; Kyushu University; Fukuoka Japan

2. Department of Respiratory Medicine; Fukuoka University School of Medicine; Fukuoka Japan

3. Department of Pulmonary Medicine; Kyoto Prefectural University of Medicine; Kyoto Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.13112/fullpdf

Reference36 articles.

1. Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008;Delgermaa;Bull World Health Organ,2011

2. Future trends of mesothelioma mortality in Japan based on a risk function;Myojin;Ind Health,2012

3. Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005;Price;Crit Rev Toxicol,2009

4. Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center;Flores;J Thorac Oncol,2007

5. Trimodality treatment of malignant pleural mesothelioma;Batirel;J Thorac Oncol,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological basis for novel mesothelioma therapies;British Journal of Cancer;2021-07-05

2. Oncolytic adenovirus: A tool for reversing the tumor microenvironment and promoting cancer treatment (Review);Oncology Reports;2021-03-02

3. Immunotherapy for mesothelioma: a critical review of current clinical trials and future perspectives;Translational Lung Cancer Research;2020-02

4. Heterogeneous Contributing Factors in MPM Disease Development and Progression: Biological Advances and Clinical Implications;International Journal of Molecular Sciences;2018-01-13